US Map / Nevada
State NV

Clinical Trials in Nevada

Nevada is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Nevada and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 85 actively recruiting studies with Nevada sites out of 85 registered in total. The busiest research areas in Nevada are Obesity, Breast Cancer, Acute Myeloid Leukemia. Leading sponsors running trials in the state include AstraZeneca, Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network. By stage, Nevada trials break down as Phase 1 (7), Phase 2 (22), Phase 3 (40), Phase 4 (6).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
85
Recruiting Now
85
← Back to US Map
Top Conditions in Nevada
Obesity (3)Breast Cancer (3)Acute Myeloid Leukemia (3)Endometrial Cancer (3)Systemic Lupus Erythematosus (2)ADHD (2)Overweight (2)Crohn's Disease (2)Atherosclerotic Cardiovascular Disease (1)Major Depressive Disorder (MDD) (1)Diabetic Retinopathy (1)Anatomic Stage IV Breast Cancer AJCC v8 (1)

Frequently Asked Questions — Clinical Trials in Nevada

How many clinical trials are currently recruiting in Nevada?
ClinicalMetric currently tracks 85 actively recruiting clinical trials with at least one location in Nevada. The total number of registered studies—including active but not currently enrolling trials—is 85. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Nevada?
Nevada hosts clinical trials across a broad range of medical conditions, including Obesity, Breast Cancer, Acute Myeloid Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Nevada serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Nevada?
To join a clinical trial in Nevada, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Nevada maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Nevada

NCT06875973 Phase 3
Recruiting
Pelacarsen Roll-over Extension Program
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
599 pts
Location
United States, Puerto Rico
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07300969 Phase 2
Recruiting
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Condition
Major Depressive Disorder (MDD)
Enrollment
300 pts
Location
United States, Bulgaria, Czechia
Sponsor
Draig Therapeutics Ltd
View Trial →
NCT07592273 Phase 2, Phase 3
Recruiting
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Particip...
Condition
Diabetic Retinopathy
Enrollment
576 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT07165028 Phase 3
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrollment
4,500 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
View Trial →
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
View Trial →
NCT06576271 Phase 1
Recruiting
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE...
Condition
Systemic Lupus Erythematosus
Enrollment
142 pts
Location
United States, Argentina, Brazil
Sponsor
GlaxoSmithKline
View Trial →
NCT07794150 Phase 1
Recruiting
A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgest...
Condition
Menopause
Enrollment
250 pts
Location
United States, India
Sponsor
Corium Innovations, Inc.
View Trial →
NCT07288398 Phase 3
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Condition
Pulmonary Hypertension Associated With HFpEF
Enrollment
540 pts
Location
United States, Argentina, Austria
Sponsor
Tenax Therapeutics, Inc.
View Trial →
NCT06594068 Phase 4
Recruiting
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in A...
Condition
Systemic Lupus Erythematosus
Enrollment
16 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07717892 Phase 3
Recruiting
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOC...
Condition
ADHD
Enrollment
468 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
View Trial →
NCT06516653 N/A
Recruiting
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistul...
Condition
End Stage Renal Disease
Enrollment
300 pts
Location
United States
Sponsor
Laminate Medical Technologies
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT07684235 Phase 3
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of ...
Condition
Obesity
Enrollment
3,200 pts
Location
United States, Australia, Japan
Sponsor
Amgen
View Trial →
NCT05624996 Phase 3
Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
474 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT07477704 Phase 2
Recruiting
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult P...
Condition
Hypercholesterolemia
Enrollment
420 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07673016 N/A
Recruiting
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platf...
Condition
Bladder Cancer
Enrollment
2,500 pts
Location
United States, Puerto Rico
Sponsor
Convergent Genomics, Inc.
View Trial →
NCT06581328 Phase 4
Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in t...
Condition
Ulcerative Colitis
Enrollment
400 pts
Location
United States
Sponsor
Takeda
View Trial →
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
View Trial →
NCT06521372 N/A
Recruiting
The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using ...
Condition
Infertility Primary
Enrollment
450 pts
Location
United States
Sponsor
Ovation Fertility
View Trial →
NCT05737121 Phase 2
Recruiting
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidoc...
Condition
Interstitial Cystitis
Enrollment
120 pts
Location
United States
Sponsor
Vaneltix Pharma, Inc.
View Trial →
NCT05232916 Phase 3
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (...
Condition
Breast Cancer
Enrollment
2,250 pts
Location
United States, Belgium, France
Sponsor
Greenwich LifeSciences, Inc.
View Trial →
NCT07747103 Phase 3
Recruiting
An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North ...
Condition
Hypothyroidism
Enrollment
466 pts
Location
United States
Sponsor
Neuvosyn Laboratories, LLC
View Trial →
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participant...
Condition
B-cell Malignancy
Enrollment
645 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
View Trial →
Page 1 of 4 — 85 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology